Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- TQA2225AP025Phase 21 trial
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Non-alcoholic Steatohepatitis
- TQA3334Phase 21 trial
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chronic Hepatitis B
- TQB3126Phase 21 trial
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Breast Cancer
- TQB3201Phase 21 trial
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Metastatic Castration-resistant Prostate Cancer
- TQB3617Phase 21 trial
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Myelofibrosis
- TQC3721Phase 21 trial
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Pulmonary Disease, Chronic Obstructive
- TQD3524Phase 21 trial
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia
- TRA16Phase 21 trial
Wuhan Kangfude Urolithiasis Research Institute Co., Ltd. · Enteric Hyperoxaluria
- TRCN-1023Phase 21 trial
Trace Neuroscience, Inc. · Amyotrophic Lateral Sclerosis
- TrevogrumabREGN1033, GDF8Phase 21 trial
Regeneron · Obesity
- TRG-200Phase 21 trial
Trigone Pharma Ltd. · Overactive Bladder (OAB)
- TRI-611Phase 21 trial
TRIANA Biomedicines, Inc. · ALK-positive NSCLC, ALK-Positive Lung Cancer, ALK-positive Non-small Cell Lung Cancer
- TRIV-509Phase 21 trial
Triveni Bio · Atopic Dermatitis
- TRIV-573Phase 21 trial
Triveni Bio · Atopic Dermatitis
- TrizepatidePhase 21 trial
Novo Nordisk · Diabetes Mellitus, Type 2
- TRL1068Phase 21 trial
Trellis Bioscience LLC · Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee
- TRTL-913Phase 21 trial
Tortugas Neuroscience, Inc. · Tinnitus
- TRTP-101Phase 21 trial
CellinCells · Atrophic Scar
- TRX103Phase 21 trial
Tr1X, Inc. · Crohns Disease
- TRX319Phase 21 trial
Tr1X, Inc. · Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis (SPMS), Multiple Sclerosis
- TRYP-0082Phase 21 trial
TRYP Therapeutics · Irritable Bowel Syndrome
- TSRA-196Phase 21 trial
Tessera Therapeutics, Inc. · Alpha-1 Antitrypsin Deficiency (AATD)
- TST003Phase 21 trial
Transcenta Therapeutics (Hangzhou) Co., Ltd. · Locally Advanced Solid Tumor, Metastatic Tumor, Colorectal Adenocarcinoma
- TT-01488Phase 21 trial
TransThera Sciences (Nanjing), Inc. · Mantle Cell Lymphoma (MCL)
- TT-10Phase 21 trial
Portage Biotech · Renal Cell Cancer, Castrate Resistant Prostate Cancer, Non Small Cell Lung Cancer
- TTYP01Phase 21 trial
Shanghai Auzone Biological Technology Co., Ltd. · Autism Spectrum Disorder (ASD)
- TU-100Phase 21 trial
Tsumura USA · Delay in GI Recovery/Postoperative Ileus (POI)
- TUB-030Phase 21 trial
Gilead Sciences · Advanced Solid Tumors, HNSCC, SCLC
- TuspetinibHM43239Phase 21 trial
Aptose Biosciences Inc. · Leukemia, Myeloid, Acute, Refractory AML, Relapsed Adult AML
- TXN10128Phase 21 trial
Txinno Bioscience Inc. · NSCLC (Non-small Cell Lung Cancer)
- TY-302Phase 21 trial
TYK Medicines, Inc · Metastatic Castration-resistant Prostate Cancer (mCRPC)
- TYK-01054Phase 21 trial
TYK Medicines, Inc · Solid Tumor Malignancies, Malignant Mesothelioma (MM)
- U16Phase 21 trial
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd · Relapsed or Refractory Non-Hodgkin's Lymphoma
- UB-421Phase 21 trial
UBP Greater China (Shanghai) Co., Ltd · HIV-1-infection
- UCART20x22Phase 21 trial
Cellectis S.A. · B-cell Non-Hodgkin Lymphoma (B-NHL)
- UCART22Phase 21 trial
Cellectis S.A. · B-cell Acute Lymphoblastic Leukemia
- UCB0022Phase 21 trial
UCB · Parkinson Disease
- UCB1381Phase 21 trial
UCB · Atopic Dermatitis
- UI-102Phase 21 trial
United Immunity, co., Ltd. · Advanced Cancer
- UKK-0018Phase 21 trial
Ukko Inc · Peanut-Induced Anaphylaxis, Peanut Allergy
- UnasnemabMT-3921Phase 21 trial
Tanabe Pharma America, Inc. · Spinal Cord Injury
- UX016Phase 21 trial
Ultragenyx Pharmaceutical Inc · GNE Myopathy
- VAL-083Phase 21 trial
Kintara Therapeutics, Inc. · Glioma, Glioblastoma, Glioblastoma Multiforme
- ValaciclovirPhase 21 trial
Trogenix ltd · Glioblastoma (GBM), High Grade Gliomas, Recurrent Glioblastoma
- VAX-24Phase 21 trial
Vaxcyte, Inc. · Pneumococcal Vaccines
- VB15010Phase 21 trial
Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Cancer, Neoplasms, Neoplasms, Breast
- VB19055Phase 21 trial
Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Hypertension, Resistant Hypertension, Uncontrolled Hypertension
- VBC101Phase 21 trial
VelaVigo Bio Inc · Participants With Advanced Solid Tumor Malignancies
- VBC103Phase 21 trial
VelaVigo Bio Inc · Participants With Advanced Solid Tumor Malignancies
- VBC106Phase 21 trial
VelaVigo Bio Inc · Participants With Advanced Solid Tumor Malignancies
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.